Finally, we confirmed a critical role of the EZH2-TPH1-5-HT-5-HT7 axis in gemcitabine-resistant pancreatic cancer growth in an in vivo xenograft tumor model. This evidence concerns the gene TPH1 and familial pancreatic carcinoma.